-
Mashup Score: 1
Background A protracted Ebola Virus Disease (EVD) epidemic in the eastern Ituri, North and South Kivu provinces of the Democratic Republic of Congo (DRC) caused 3470 confirmed and probable cases between July 2018 and April 2020. During the epidemic, the International Federation of Red Cross and Red Crescent Societies (IFRC) supported the DRC Red Cross and other local actors to offer safe and dignified burials (SDB) for suspected and confirmed EVD cases, so as to reduce transmission associated with infectious dead bodies. We conducted a retrospective cohort study of the SDB service’s performance in order to inform future applications of this intervention. Methods We analysed data on individual SDB responses to quantify performance based on key indicators and against pre-specified service standards. Specifically, we defined SDB timeliness as response within 24 h and success as all components of the service being implemented. Combining the database with other information sources, we also
Source: bmcmedicine.biomedcentral.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Ebola virus disease in children: epidemiology, pathogenesis, management, and prevention - Pediatric Research - 6 month(s) ago
Ebola disease is a severe disease with extremely high case-fatality rates ranging from 28–100%. Observations made during the 2013–2016 West African epidemic improved our understanding of the clinical course of Ebola disease and accelerated the study of therapeutic and preventative strategies. The epidemic also highlighted the unique challenges associated with providing optimal care for children…
Source: www.nature.comCategories: General Medicine News, Infectious DiseaseTweet-
Dr. Katherine Dobbs and the team at @CWRUSOM summarize recent advancements in our understanding of #Ebola disease epidemiology, 🩺 clinical presentation, and therapeutic and preventative strategies. @Ped_Research | https://t.co/uasWi4lFIV https://t.co/8f1VGaTGc7
-
-
Mashup Score: 7Single-cell profiling of lncRNA expression during Ebola virus infection in rhesus macaques - 9 month(s) ago
Nature Communications – Long non-coding RNAs (lncRNAs) play key roles in the immune response but their properties at the single-cell level are less well understood. Here, the authors characterize…
Source: www.nature.comCategories: General Medicine News, Latest HeadlinesTweet-
Single-cell profiling of lncRNA expression during #Ebola virus infection in rhesus macaques @SantusLuisa @mariasopenarios @PardisSabet @marta_mele_m @sabeti_lab @mele_lab @broadinstitute @BSC_CNS #lncRNAs #scRNAseq #virology https://t.co/ucM5gMwwod
-
-
Mashup Score: 4IAVI launches first human trial of Sudan Ebola virus vaccine - 10 month(s) ago
The phase 1 trial will enroll 36 healthy adults at two US clinical sites.
Source: www.cidrap.umn.eduCategories: Infectious Disease, Latest HeadlinesTweet-
IAVI launches first human trial of Sudan #Ebola virus vaccine The phase 1 trial will enroll 36 healthy adults at two US clinical sites https://t.co/cxMoZmyCex https://t.co/flfuo4wNFJ
-
-
Mashup Score: 62Ebola outbreak 2018-2020- North Kivu-Ituri - 1 year(s) ago
The Democratic Republic of the Congo is grappling with the world’s second largest ebola epidemic on record.
Source: www.who.intCategories: Healthcare Professionals, Latest HeadlinesTweet-
Thanks to heroic efforts by Dr Richard and thousands more health workers, the world’s second largest #Ebola outbreak across eastern #DRC was contained. Amid ongoing armed conflict, they conducted a complex vaccination campaign, treated patients, and more. https://t.co/nRqbtoW3Uc
-
-
Mashup Score: 0Sudan Ebola virus (SUDV) outbreak in Uganda, 2022: lessons learnt and future priorities for sub-Saharan Africa - BMC Medicine - 1 year(s) ago
BMC Medicine volume 21, Article number: 144 (2023) Cite this article Background On 20th September 2022, the Ugandan Ministry…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In this Commentary, Godfrey Bwire and colleagues call for action to invest in critical areas to rapidly prevent, mitigate and respond to future Sudan #Ebola #virus outbreaks in sub-Saharan #Africa @MinofHealthUG @MakSPH - read the full story here: https://t.co/tSFk9pDVI2 https://t.co/tngLNCS4yP
-
-
Mashup Score: 1Tanzania reports a Marburg outbreak, Africa’s second this year - 1 year(s) ago
Africa is grappling with not one, but two outbreaks of Marburg fever, a disease that causes symptoms and a death rate comparable to Ebola, its viral cousin.
Source: STATCategories: Expert Picks, Latest HeadlinesTweet-
Africa is grappling with not one, but two outbreaks of #Marburg fever, a disease that causes symptoms and a death rate comparable to #Ebola, its viral cousin. https://t.co/wUP2C0wsZ3 via @statnews
-
-
Mashup Score: 23Tanzania reports a Marburg outbreak, Africa’s second this year - 1 year(s) ago
Africa is grappling with not one, but two outbreaks of Marburg fever, a disease that causes symptoms and a death rate comparable to Ebola, its viral cousin.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
Even countries with experience with #Ebola and #Marburg outbreaks can struggle to control them, says Gary Kobinger, who has worked on a bunch. https://t.co/gCEazXf1Dm
-
-
Mashup Score: 14An early lesson from the Uganda Ebola vaccine trial: Shots must be ready to go before the next outbreak strikes - 1 year(s) ago
Had these experimental Ebola vaccines been available to push into the field earlier, in ready-to-use vials, the trial starting in Uganda this week might have been more useful.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
2. Developers trying to scrounge up #Marburg vaccine doses to test were just weeks ago scrambling to do the same for #Ebola Sudan vaccines to trial in Uganda's outbreak. It ended before that could work could be done. There's got to be a better way. https://t.co/Xa8N8s7zqr
-
-
Mashup Score: 7Ebola Vaccines Safe and Immunogenic in 2 Trials - 1 year(s) ago
Three vaccine regimens against Zaire Ebola virus disease safely produced immune responses for up to 12 months, according to 2 trials of adults and children reported in the New England Journal of Medicine.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Three vaccine regimens against Zaire Ebola virus disease safely produced immune responses for up to 12 months in 2 trials involving adults and children. Vaccine efficacy could not be evaluated because no #Ebola cases occurred during the trial. https://t.co/wtlf1AAhvh #MedicalNews
-
Abdihamid Warsame et al. analyse data on safe and dignified burials (SDB) for suspected & confirmed #Ebola Virus Disease (EVD) cases in Democratic Republic of the Congo, finding SDB service proved feasible during the EVD outbreak in 2018–2019: https://t.co/kRYMUjL3Y5 https://t.co/OqVyofn94H